What You Should Know:
- LA-based Scanwell Health announced today that its at-home UTI test kits - featuring the first FDA-cleared urinalysis app that lets people test for a UTI without having to visit a lab or doctor - is now available on Amazon.com.
- The kits are priced at 3 for $15. Happy to send a graphic or answer any questions you have. Until now, the kits have been available only directly through the Scanwell Health web site.
- Scanwell enables clinical-grade testing, instant
Read More
Banner Health, WellSpan, Others Invest in Virtual Maternity Care Platform Babyscripts
What You Should Know:
- Virtual maternity care platform Babyscripts announced a
new round of investments from Banner Health, CU Healthcare Innovation Fund, The
Froedtert & Medical College of Wisconsin Health Network, and WellSpan
Health
- Using internet-connected devices for remote monitoring,
Babyscripts offers risk-specific experiences to allow providers to manage up to
90% of pregnancies virtually, allowing doctors to detect risk more quickly and
automate elements of
Read More
Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms
What You Should Know:
- Lightspeed Venture Partners, the VC behind Nest and GrubHub, is leading a $10 million round for Freespira, an FDA-cleared digital therapeutic proven to significantly reduce or eliminate panic attacks and PTSD symptoms by training users to normalize respiratory irregularities.
- In 28 days, Freespira can reduce or eliminate panic
attacks and PTSD symptoms from home with just a tablet, sensor, and custom app.
There’s no medicine with possible side effects and no need
Read More
Pear Therapeutics Raises $80M to Advance Prescription Digital Therapeutics
What You Should Know:
- Pear Therapeutics today announced that it has
successfully closed an $80 million Series D financing led by SoftBank Vision
Fund 2.
- Pear is the
leader in prescription digital therapeutics and the first company to receive
FDA authorization for a prescription digital therapeutic (PDT) to treat
disease.
- Pear currently has three FDA authorized therapies, reSET, reSET-O and Somryst, for substance use disorder, opioid use disorder, and chronic insomnia,
Read More
Amazon Launches HealthLake for Healthcare Orgs to Aggregate & Structure Health Data
What You Should Know:
- Amazon today announced the launch of Amazon HealthLake,
a new HIPAA-eligible service enables healthcare organizations to store, tag,
index, standardize, query, and apply machine learning to analyze data at
petabyte scale in the cloud.
- Cerner, Ciox Health, Konica Minolta Precision Medicine,
and Orion Health among customers using Amazon HealthLake.
Today at AWS re:Invent, Amazon
Web Services, Inc. (AWS), an Amazon.com company today announced Amazon
Read More
Cerner Invests in Elligo to Make Clinical Trials Accessible for Health Systems of All Sizes
What You Should Know:
- Cerner announced a strategic investment in Elligo
Health Research, a leading research organization that enables clinical trials
with nationwide community-based health care practices.
- Cerner plans to expand the data and tools available in
the Cerner Learning Health Network to offer additional clinical trial resources
to community and rural hospitals and physician practices.
- Financial terms of strategic investment were not disclosed.
Cerner
Read More
Innovaccer Launches COVID-19 Command Center to Help Healthcare Organizations Manage Their COVID-19 Operations
What You Should Know:
- Innovaccer launches COVID-19 Command
Center to assist healthcare organizations in optimizing their COVID-19
operations.
- The solution offers a unified
information hub to manage COVID-19 resources and operations and empower teams
with unprecedented visibility into their environment.
Innovaccer, Inc., a San
Francisco, CA-based healthcare technology company, today announced the launch
of its COVID-19
Command Center to assist healthcare organizations in
Read More
Backed by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery Platform
What You Should Know:
- Biopharma startup Rubedo Life Sciences raises $12M to develop a broad portfolio of innovative therapies engineered to target cells for chronic age-related diseases.
- Rubedo’s proprietary ALEMBIC™ drug discovery platform, has generated a novel pipeline of therapeutic candidates that selectively target senescent cells, pro-inflammatory and pro-fibrotic cell populations that result from a variety of cellular stress and damage.
Rubedo Life Sciences, a
Read More
Everlywell Secures $175M to Expand Position in At-Home Testing Market
What You Should Know:
- Everlywell secures $175M in Series D funding to expand
its virtual care offerings, scale its testing and infrastructure, drive
clinical research and disease management through testing, and grow its national
leadership position in the at-home testing market.
- Since launching in 2016, more than one million people have used Everlywell's tests and digital platform to manage their health and wellness. As more people turn toward digital platforms for their health
Read More
Northwell Health Offers COVID-19 Screening Chat for NY Schools and Employers
What You Should Know:
- Northwell Health announced that its Northwell Direct unit, which works with large employers, will be offering Conversa HealthCheck to screen employees, customers, students, and visitors.
- HealthCheck is a quick, chat-based electronic screening
for symptoms and signs of exposure to COVID-19. If cleared, users receive a
digital "badge" that allows entry to a facility. If not cleared, they
are given additional information on staying home and steps for testing
Read More
